Open AccessTriple-Negative Breast Cancer: Assessing the Role of Immunohistochemical Biomarkers on Neoadjuvant Treatment
Author(s) -
Jessé Lopes da Silva,
Fabiana Resende Rodrigues,
Guilherme Gomes de Mesquita,
Priscila Valverde Fernandes,
Luiz Cláudio Santos Thuler,
Andréia Cristina de Melo
Publication year - 2021
Publication title -
breast cancer
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 1.19
H-Index - 27
ISSN - 1179-1314
DOI - 10.2147/bctt.s287320
Subject(s) - medicine , immunohistochemistry , breast cancer , oncology , surgical oncology , stage (stratigraphy) , biomarker , triple negative breast cancer , lymph node , neoadjuvant therapy , androgen receptor , cancer , prostate cancer , paleontology , biochemistry , chemistry , biology
This study aimed to investigate the influence of immunohistochemical (IHC) biomarkers in the response to neoadjuvant chemotherapy (NACT) and survival outcomes in the subset of locally advanced triple-negative breast cancer (TNBC).